Adagio Medical Holdings, Inc. (ADGM) stock
ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.65+0.04 (+2.48%)
Close on Nov 17, 2026Market cap $1.37MP/E –Yield –
Adagio Medical r&d expenses
Research and development expenses are spending on new products and technology.
Adagio Medical's R&D Expenses for the twelve months ending Sep 30, 2026 was $9.23M. For fiscal 2025 it was $10.64M, down 30.9% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.64M | -30.9% |
| FY2023 | Dec 31, 2023 | $15.40M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.80M | -35.1% |
| Q2 FY2026 | Jun 30, 2026 | $2.45M | +24.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.74M | -25.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.24M | -22.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.77M | -20.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.97M | +11.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.66M | -17.2% |
| Q2 FY2024 | Jun 30, 2024 | $2.87M | – |
| Q1 FY2024 | Mar 31, 2024 | $3.47M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.77M | – |
| Q3 FY2023 | Sep 30, 2023 | $4.42M | – |
See a number that looks wrong?